EUVIMEDEUVIMED entdecken
Crossref

Hepatobiliary disease after bone marrow transplant: A cross‐sectional study of 377 patients

Maria Gabriela Fernandes Dezan, Lourianne Nascimento Cavalcante, Hugo Rodrigues Carvalho Silva, Alessandro de Moura Almeida, Luiz Henrique Dos Santos de Assis, Tiago Thalles de Freitas, Marco Aurélio Salvino de Araújo, Helma Pinchemel Cotrim, Andre Castro Lyra iD

Alimentary Pharmacology & Therapeutics · 2024

DOI: 10.1111/apt.17756 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2024. Verfasst von Maria Gabriela Fernandes Dezan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Instituto D'Or de Pesquisa e Ensino (IDOR) and Hospital São Rafael-Gastro-Hepatology Service, Hospital São Rafael, Salvador, Bahia, Brazil. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hepatitis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bone marrow transplantation (BMT) is a standard treatment for several haematologic conditions. Following BMT, patients may develop hepatobiliary complications that impact morbidity and mortality. The differential diagnosis may include drug‐induced liver injury (DILI), sepsis‐associated liver injury (SALI), sinusoidal obstruction syndrome (SOS), graft‐versus‐host disease (GVHD), viral hepatitis, ischaemic hepatitis, and fulminant hepatitis.

Aims

To evaluate the frequency, clinical characteristics, and outcomes of patients with hepatobiliary alterations associated with BMT in a tertiary referral centre.

Methods

This was a cross‐sectional study with data collected from the medical records of patients undergoing BMT between January 2017 and June 2022. We diagnosed hepatobiliary complications based on established criteria.

Results

We included 377 patients; 55.7% had hepatobiliary complications. Female gender, pre‐BMT hepatobiliary alteration, and haploidentical allogeneic transplantation were associated with increased risk with odds ratios (OR) of 1.8 ( p = 0.005), 1.72 ( p = 0.013) and 3.25 ( p = 0.003), respectively. Patients with hepatobiliary complications spent longer in the hospital than those without (27.7 × 19.3 days, respectively; p < 0.001). Among 210 patients with hepatobiliary complications, 28 died compared to 5 of 167 without complications (OR 4.98; p = 0.001).

Conclusions

Hepatobiliary complications are frequent in patients undergoing BMT. There is a greater risk of their occurrence in women, people with pre‐BMT liver alterations, and in haploidentical transplants. The occurrence of these complications increases the length of stay and is associated with a higher risk of death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseHepatitisHumansFemaleBone Marrow TransplantationCross-Sectional StudiesBone MarrowTransplantation, Homologous

Autor:innen und Institutionen

  • Instituto D'Or de Pesquisa e Ensino (IDOR) and Hospital São Rafael-Gastro-Hepatology Service, Hospital São Rafael, Salvador, Bahia, Brazil.
  • Gastro-Hepatology Service-University Hospital Professor Edgard Santos (HUPES), Federal University of Bahia, Salvador, Bahia, Brazil.
  • Postgraduate Program in Medicine and Health, Federal University of Bahia, Salvador, Bahia, Brazil.
  • Instituto D'Or de Pesquisa e Ensino (IDOR) and Hospital São Rafael-Hematology Service, Hospital São Rafael, Salvador, Bahia, Brazil.
  • Hematology Service-University Hospital Professor Edgard Santos (HUPES), Federal University of Bahia, Salvador, Bahia, Brazil.

ORCID-Profile: Andre Castro Lyra

Zitieren

APA

Dezan, M. G. F., Cavalcante, L. N., Silva, H. R. C., de Moura Almeida, A., Dos Santos de Assis, L. H., de Freitas, T. T., de Araújo, M. A. S., Cotrim, H. P., & Lyra, A. C. (2024). Hepatobiliary disease after bone marrow transplant: A cross‐sectional study of 377 patients. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17756

Vancouver

Dezan MGF, Cavalcante LN, Silva HRC, de Moura Almeida A, Dos Santos de Assis LH, de Freitas TT, et al. Hepatobiliary disease after bone marrow transplant: A cross‐sectional study of 377 patients. Alimentary Pharmacology & Therapeutics. 2024. doi:10.1111/apt.17756

BibTeX
@article{Dezan2024,
  author = {Dezan, Maria Gabriela Fernandes and Cavalcante, Lourianne Nascimento and Silva, Hugo Rodrigues Carvalho and de Moura Almeida, Alessandro and Dos Santos de Assis, Luiz Henrique and de Freitas, Tiago Thalles and de Araújo, Marco Aurélio Salvino and Cotrim, Helma Pinchemel and Lyra, Andre Castro},
  title = {Hepatobiliary disease after bone marrow transplant: A cross‐sectional study of 377 patients},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2024},
  doi = {10.1111/apt.17756}
}
Kostenlos starten →